牛牛AI助理已提取核心訊息
Merck & Co. Inc. officer Rita Karachun is set to sell 26,402 common shares of the company, with an aggregate market value of approximately $3.3 million, on February 14, 2024. The shares to be sold were acquired on the same date through the exercise of options under a registered plan, with the acquisition made directly from the issuer and paid for in cash. There is no recent transaction history reported for the past three months prior to this notice.
Merck & Co. Inc. officer Rita Karachun is set to sell 26,402 common shares of the company, with an aggregate market value of approximately $3.3 million, on February 14, 2024. The shares to be sold were acquired on the same date through the exercise of options under a registered plan, with the acquisition made directly from the issuer and paid for in cash. There is no recent transaction history reported for the past three months prior to this notice.
默沙東公司公司高管麗塔·卡拉春定於2024年2月14日出售該公司的26,402股普通股，總市值約爲330萬美元。待出售的股票是通過行使註冊計劃下的期權於同日收購的，收購直接從發行人那裏進行，並以現金支付。在本通知之前的過去三個月中，沒有報告最近的交易記錄。
默沙東公司公司高管麗塔·卡拉春定於2024年2月14日出售該公司的26,402股普通股，總市值約爲330萬美元。待出售的股票是通過行使註冊計劃下的期權於同日收購的，收購直接從發行人那裏進行，並以現金支付。在本通知之前的過去三個月中，沒有報告最近的交易記錄。
有用
沒用